SCIENCE IN THE NEWS DAILY
Drug Companies Drain Scientific Brains from FDA
from USA Today
WASHINGTON (Associated Press) - When pharmaceutical consulting firm Quintiles wants to hire a new employee, the first place it looks is the Food and Drug Administration. These former insiders bring critical expertise to the consultant and clients like Merck & Co. and Pfizer, but there is also an unintended downside.
As companies siphon off FDA's most experienced scientists, they leave an increasingly leaner, less confident staff that is hesitant to put new drugs on the market, analysts say.
FDA's staffing pains -- exacerbated by the departure of a baby boomers and increasing competition for science graduates -- has caught the attention of lawmakers and consumers, who blame declining inspections for a string of problems with tainted food and drugs.
Read more ...
Connect With Us:
PODCAST & VIDEO: 3D Printing Replacement Body Parts
Regenerative medicine, a fledgling field with the aim of regrowing parts from a person’s own cells, is being amplified with 3D-printing technology, which can now use organic materials to create scaffolds that cells need to grow into their final forms. Richard Wysk, a professor of industrial and systems engineering at North Carolina State University, discusses the latest successes with this research, and the timeline for creating more complicated structures.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.